...
首页> 外文期刊>Clinical and experimental ophthalmology >Diode laser trans-scleral cyclophotocoagulation for glaucoma following silicone oil removal.
【24h】

Diode laser trans-scleral cyclophotocoagulation for glaucoma following silicone oil removal.

机译:去除硅油后,二极管激光经巩膜环光凝治疗青光眼。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To evaluate the effect of trans-scleral cyclophotocoagulation (TSCP) on intraocular pressure (IOP) in eyes with medically uncontrolled secondary glaucoma persisting after intravitreal silicone oil removal. METHODS: Clinical records of 21 eyes of 21 patients who underwentTSCP for medically uncontrolled glaucoma persisting after the removal of intravitreal silicone oil, injected during vitreoretinal surgery for proliferative vitreoretinopathy (PVR), were reviewed retrospectively. Diode laser contactTSCP was applied at a power setting of 1.5-2.5 W, for a maximum duration of 2 s, and a total of 40 spots (10 spots each quadrant). All the patients were evaluated for visual acuity, IOP and number of medications used. RESULTS: The patients were followed up for a mean +/- SD period of 39.9 +/- 4.27 weeks (range 36-48 weeks).The IOP was found to have decreased significantly from a pretreatment value of 34.5 +/- 5.37 mmHg (range 24-44 mmHg) to 20.47 +/- 4.49 mmHg at 6 months of follow up (range 12-30 mmHg, P < 0.01, Student's paired t-test). The total number of glaucoma medications being used reduced from 3.38 +/- 0.5 to 1.08 +/- 0.80 postoperatively (P < 0.01, Wilcoxon's rank sum test).There was no significant difference in the visual acuity before and after the procedure. Thirteen eyes required a second sitting of TSCP, and five of these required a third sitting. For a successful outcome (IOP < 24 mmHg), a mean of 1.56 sittings (range 1-3 sittings) per eye were needed. CONCLUSION: Patients with medically uncontrolled glaucoma persisting after intravitreal silicone oil removal can be treated with TSCP; however, the reduction of IOP is variable. The IOP usually falls after a mean of 2-3 sittings of
机译:目的:评估经巩膜环光凝术(TSCP)对玻璃体内硅油去除后持续存在医学上不受控制的继发性青光眼的眼内压(IOP)的影响。方法:回顾性分析21例因玻璃体视网膜手术增生性玻璃体视网膜病变(PVR)注射的玻璃体内硅油清除后因医学上无法控制的青光眼而持续进行TSCP的21眼患者的临床记录。二极管激光接触式TSCP的功率设置为1.5-2.5 W,最大持续时间为2 s,共有40个光斑(每个象限10个光斑)。对所有患者进行视力,眼压和所用药物数量的评估。结果:对患者进行了39.9 +/- 4.27周的平均+/- SD周期(范围36-48周),发现IOP与治疗前的34.5 +/- 5.37 mmHg值相比有显着降低(在6个月的随访中(范围24-44 mmHg)至20.47 +/- 4.49 mmHg(范围12-30 mmHg,P <0.01,学生配对t检验)。术后使用的青光眼药物总数从3.38 +/- 0.5降低至1.08 +/- 0.80(P <0.01,Wilcoxon秩和检验)。手术前后的视力没有显着差异。十三眼需要TSCP的第二次坐位,其中五眼需要第三次的坐位。为了获得成功的结果(IOP <24 mmHg),平均每只眼睛需要1.56个就座(1-3个就座范围)。结论:玻璃体腔内硅油清除后仍然存在医学上无法控制的青光眼的患者可以使用TSCP进行治疗;但是,IOP的减少是可变的。通常在平均2-3次就诊后IOP下降

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号